Ryan Cohlhepp, President and COO at Bicara Therapeutics Inc. (BCAX), sold 34,784 shares at $18.16 ($632K) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $632k BCAX by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.16 | 4,500 | $82K | 12.9% |
| 2 | $18.16 | 12,892 | $234K | 37.1% |
| 3 | $18.16 | 4,500 | $82K | 12.9% |
| 4 | $18.16 | 12,892 | $234K | 37.1% |
| Total | $18.16 avg | 34,784 | $632K | 100% |
| Filing → |
| BCAX | SELL | 2026-07-10 | $833K | — | Filing → |
| BCAX | SELL | 2026-05-18 | $254K | — | Filing → |
| BCAX | SELL | 2026-04-17 | $288K | — | Filing → |